Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s630. https://doi.org/10.25251/ej4zcr36